Terms: = Lung cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Clinical Outcome
21 results:
1. Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma.
Lin L; Wu X; Jiang Y; Deng C; Luo X; Han J; Hu J; Cao X
PeerJ; 2022; 10():e13402. PubMed ID: 35646490
[TBL] [Abstract] [Full Text] [Related]
2. Silencing FYVE, RhoGEF, and PH domain containing 1 (FGD1) suppresses melanoma progression by inhibiting PI3K/AKT signaling pathway.
Niu Z; Li Y; Xu Y; Jiang W; Tao R; Chen Y; Han Y
Bioengineered; 2021 Dec; 12(2):12193-12205. PubMed ID: 34783295
[TBL] [Abstract] [Full Text] [Related]
3. STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.
Yang Y; Wu J; Zhou H; Liu W; Wang J; Zhang Q
Cell Cycle; 2020 Jun; 19(12):1502-1516. PubMed ID: 32401659
[TBL] [Abstract] [Full Text] [Related]
4. Mechanism of lung adenocarcinoma spine metastasis induced by CXCL17.
Liu W; Xie X; Wu J
Cell Oncol (Dordr); 2020 Apr; 43(2):311-320. PubMed ID: 31832986
[TBL] [Abstract] [Full Text] [Related]
5. A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.
Sun J; Zhu M; Shen W; Wang C; Dai J; Xu L; Jin G; Hu Z; Ma H; Shen H
Pharmacogenomics J; 2017 Jun; 17(3):280-285. PubMed ID: 26951883
[TBL] [Abstract] [Full Text] [Related]
6. [Childhood pleuropulmonary blastoma: a clinicopathologic study of 16 cases].
Zhang N; Fu L; Zhou C; Wang L; Lang Z; He L
Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):747-52. PubMed ID: 25582253
[TBL] [Abstract] [Full Text] [Related]
7. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
Jia C; Mei F; Zheng J; You JF; Liu JY
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
[TBL] [Abstract] [Full Text] [Related]
8. Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer.
Franchina T; Amodeo V; Bronte G; Savio G; Ricciardi GR; Picciotto M; Russo A; Giordano A; Adamo V
J Cell Physiol; 2014 Jan; 229(1):97-9. PubMed ID: 23794259
[TBL] [Abstract] [Full Text] [Related]
9. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.
Yamashita T; Honda M; Nakamoto Y; Baba M; Nio K; Hara Y; Zeng SS; Hayashi T; Kondo M; Takatori H; Yamashita T; Mizukoshi E; Ikeda H; Zen Y; Takamura H; Wang XW; Kaneko S
Hepatology; 2013 Apr; 57(4):1484-97. PubMed ID: 23174907
[TBL] [Abstract] [Full Text] [Related]
10. SAA1 is over-expressed in plasma of non small cell lung cancer patients with poor outcome after treatment with epidermal growth factor receptor tyrosine-kinase inhibitors.
Milan E; Lazzari C; Anand S; Floriani I; Torri V; Sorlini C; Gregorc V; Bachi A
J Proteomics; 2012 Dec; 76 Spec No.():91-101. PubMed ID: 22771314
[TBL] [Abstract] [Full Text] [Related]
11. Gene expression analysis using long-term preserved formalin-fixed and paraffin-embedded tissue of non-small cell lung cancer.
Jacobson TA; Lundahl J; Mellstedt H; Moshfegh A
Int J Oncol; 2011 Apr; 38(4):1075-81. PubMed ID: 21305253
[TBL] [Abstract] [Full Text] [Related]
12. The prognostic value of intraepithelial and stromal CD3-, cd117- and CD138-positive cells in non-small cell lung carcinoma.
Al-Shibli K; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Busund LT
APMIS; 2010 May; 118(5):371-82. PubMed ID: 20477813
[TBL] [Abstract] [Full Text] [Related]
13. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract] [Full Text] [Related]
14. Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome.
Koutsopoulos AV; Mavroudis D; Dambaki KI; Souglakos J; Tzortzaki EG; Drositis J; Delides GS; Georgoulias V; Stathopoulos EN
Lung Cancer; 2007 Aug; 57(2):193-200. PubMed ID: 17442448
[TBL] [Abstract] [Full Text] [Related]
15. Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far?
Fischer B; Marinov M; Arcaro A
Cancer Treat Rev; 2007 Jun; 33(4):391-406. PubMed ID: 17368733
[TBL] [Abstract] [Full Text] [Related]
16. [A case of metastatic gastrointestinal stromal tumor developing a resistance to STI571 (imatinib mesylate)].
Miyake M; Takeda Y; Hasuike Y; Kashiwazaki M; Mishima H; Ikenaga M; Mano M; Takada Y; Hirota S; Tsujinaka T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1791-4. PubMed ID: 15553717
[TBL] [Abstract] [Full Text] [Related]
17. Novel targets for therapeutic agents in small cell lung cancer.
Ma PC; Salgia R
J Natl Compr Canc Netw; 2004 Mar; 2(2):165-72. PubMed ID: 19777705
[TBL] [Abstract] [Full Text] [Related]
18. SYT-SSX2 variant of primary pulmonary synovial sarcoma with focal expression of cd117 (c-kit) protein and a poor clinical outcome.
Boroumand N; Raja V; Jones DV; Haque AK
Arch Pathol Lab Med; 2003 Apr; 127(4):e201-4. PubMed ID: 12683902
[TBL] [Abstract] [Full Text] [Related]
19. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins.
Plaat BE; Hollema H; Molenaar WM; Torn Broers GH; Pijpe J; Mastik MF; Hoekstra HJ; van den Berg E; Scheper RJ; van der Graaf WT
J Clin Oncol; 2000 Sep; 18(18):3211-20. PubMed ID: 10986053
[TBL] [Abstract] [Full Text] [Related]
20. HER-2/neu expression in archival non-small cell lung carcinomas using FDA-approved Hercep test.
Scheurle D; Jahanzeb M; Aronsohn RS; Watzek L; Narayanan R
Anticancer Res; 2000; 20(3B):2091-6. PubMed ID: 10928158
[TBL] [Abstract] [Full Text] [Related]
[Next]
